With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.
David Blair
Advertisement
David Blair is the CEO of independent pharmacy benefit manager LucyRx.
Articles by David Blair
LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.
David Blair, CEO of LucyRx, joined Drug Topics to discuss the initiatives his company is conducting in support of a struggling pharmacy profession.
David Blair, CEO of LucyRx, discusses the common challenges his clients face and how his company’s innovative model can help them overcome financial hurdles.
In a conversation with David Blair, CEO of LucyRx, he discussed his company’s unique business model and how it is giving back to patients, providers, and plan sponsors alike.
Advertisement
Latest Updated Articles
How LucyRx is Changing the Traditional PBM ModelApril 17th 2025
LucyRx’s Role in Supporting the Pharmacist ProfessionApril 15th 2025
Advertisement
Advertisement
Trending on Drug Topics
1
Zepbound Lowers Health Care Costs in Older Adults With Obesity
2
Ixekizumab, Tirzepatide Maintains Efficacy in Psoriatic Disease
3
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
4
How mRNA and Protein-Based COVID-19 Vaccines Work
5